<DOC>
	<DOCNO>NCT01988922</DOCNO>
	<brief_summary>This research study determine genetic variation CYP2B6 affect body metabolizes ketamine .</brief_summary>
	<brief_title>CYP2B6 Polymorphisms Ketamine</brief_title>
	<detailed_description />
	<mesh_term>Ketamine</mesh_term>
	<criteria>1 . 1850 yr old 2 . CYP2B6*1/*1 , CYP2B6*1/*6 CYP2B6*6/*6 genotype ( see table ) ( Note : subject rare genotype one 516G &gt; T , 785A &gt; G , 983T &gt; C 1459C &gt; T polymorphism may enrol PI 's discretion ) 3 . Good general health remarkable medical condition 4 . BMI &lt; 33 5 . Provided informed consent 1 . Known history liver kidney disease 2 . Use prescription non prescription medication , herbal , food chemical know metabolized affect CYP2B6 3 . Females pregnant nursing 4 . Known history drug alcohol addiction ( prior present addiction treatment addiction ) 5 . Direct physical access routine handle addict drug regular course duty ( routine exclusion study drug addiction potential )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>ketamine polymorphism</keyword>
</DOC>